2021-12

GEXSCOPE® Microbial Single Cell RNA Library Kit (Yeast) launched

2021-9

Singleron Completes Series B Financing, Raising Close To $100M

2021-7

Launch of Singleron PythoN Automated Tissue Dissociation System

2021-5

Completion of Class I Medical Device Registration (Instrument)

2021-3

Singleron Matrix receives CE mark

2021-1

Completion of Class I Medical Device Registration (reagents)

2020-12

Singleron Completes Series A2 Financing，Raising Close to $30M

2020-11

Singleron Completes Series A1 Financing, Raising More Than $10M

2020-9

Series A financing led by Lilly Asia Ventures

2020-6

Singleron Matrix™ launched

2020-4

German Laboratory and Office, Cologne

2020-2

US Laboratory and Office, Woodridge, CT

2020-1

Singleron single cell sequencing as part of clinical trial officially approved by National Human Genetic Resources Office in China (GH0044)

2019-11

Eighth Chinese National Innovation and Entrepreneurship Contest, Outstanding Enterprise Award (National Level)

2019-6

Pre-Series A Financing worth more than $10M, led by Sherpa Capital and co-invested by China Growth Capital and existing investors

2019-01

GEXSCOPE® Single Cell RNA Kit V1 launched

2018-11

Seventh Chinese National Innovation and Entrepreneurship Contest, Outstanding Enterprise Award (National Level)

2018-5

Closed Seed Round financing led by Oriza Seed Fund and co-invested by FreeS VC

2018-2

Exclusive licensing of key IP from Yale University

2018-1

Singleron Biotechnologies Ltd. incorporated